Joseph Rodriguez
Overview
Explore the profile of Joseph Rodriguez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1654
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kornacki C, Rodriguez J, Rodriguez J, Hurtado A, Lee J, Moore R, et al.
Am Indian Alsk Native Ment Health Res
. 2025 Mar;
32(1):1-24.
PMID: 40029255
American Indian and Alaska Native (AI/AN) youth have the highest commercial tobacco smoking rate of any group in the United States. Unified by the aim to reduce AI/AN youth commercial...
2.
Franzoi M, Ferreira A, Lemaire A, Rodriguez J, Grosjean J, Ribeiro J, et al.
Lancet Reg Health Eur
. 2024 Oct;
44:101005.
PMID: 39444707
Background: Remote patient monitoring (RPM) of symptoms using electronic patient reported outcomes (ePROs) has been shown to reduce symptom burden and hospitalizations, increase dose intensity and improve quality of life...
3.
Wan M, Liu Y, Li D, Snyder R, Elkin L, Day C, et al.
Nucleic Acids Res
. 2024 Aug;
52(17):10235-10254.
PMID: 39162226
Enhancers, critical regulatory elements within the human genome, are often transcribed into enhancer RNAs. The dysregulation of enhancers leads to diseases collectively termed enhanceropathies. While it is known that enhancers...
4.
Abahssain H, Souadka A, Alem R, Santoni M, Battelli N, Amela E, et al.
Curr Oncol
. 2024 Jul;
31(7):3771-3782.
PMID: 39057150
Background: Triple-negative breast cancer (TNBC) remains a clinically challenging subtype due to its aggressive nature and limited treatment options post-neoadjuvant failure. Historically, capecitabine has been the cornerstone of adjuvant therapy...
5.
Daugird T, Shi Y, Holland K, Rostamian H, Liu Z, Lavis L, et al.
Nat Commun
. 2024 May;
15(1):4178.
PMID: 38755200
In the nucleus, biological processes are driven by proteins that diffuse through and bind to a meshwork of nucleic acid polymers. To better understand this interplay, we present an imaging...
6.
Kornacki C, Rodriguez J, Rodriguez J, Calac A, Calac D, Lee J, et al.
Nicotine Tob Res
. 2024 May;
26(11):1582-1585.
PMID: 38747187
Introduction: High prevalence of commercial tobacco product (CTP) use among American Indian and Alaska Native (AI/AN) youth is a public health crisis. A multi-level Tribal-community-based participatory research project under Tribal...
7.
Liem X, De Baere T, Vivar O, Seiwert T, Shen C, Papai Z, et al.
Head Neck
. 2024 Apr;
46(6):1253-1262.
PMID: 38600434
Background: An international multidisciplinary panel of experts aimed to provide consensus guidelines describing the optimal intratumoral and intranodal injection of NBTXR3 hafnium oxide nanoparticles in head and neck squamous cell...
8.
Daugird T, Shi Y, Holland K, Rostamian H, Liu Z, Lavis L, et al.
bioRxiv
. 2023 Nov;
PMID: 38014222
In the nucleus, biological processes are driven by proteins that diffuse through and bind to a meshwork of nucleic acid polymers. To better understand this interplay, we developed an imaging...
9.
Gordon J, Chapus F, Viverette E, Williams J, Deterding L, Krahn J, et al.
Nat Commun
. 2022 Nov;
13(1):6783.
PMID: 36351913
PELP1 (Proline-, Glutamic acid-, Leucine-rich protein 1) is a large scaffolding protein that functions in many cellular pathways including steroid receptor (SR) coactivation, heterochromatin maintenance, and ribosome biogenesis. PELP1 is...
10.
Hoffman J, Trotter K, Day C, Ward J, Inoue K, Rodriguez J, et al.
Mol Cell
. 2022 Jan;
82(4):803-815.e5.
PMID: 35077705
The hormone-stimulated glucocorticoid receptor (GR) modulates transcription by interacting with thousands of enhancers and GR binding sites (GBSs) throughout the genome. Here, we examined the effects of GR binding on...